Innovation in European healthcare – what can Sweden learn? - LIF

The Innovation environments invest in the early phase
before private venture capital will even consider
investments
On behalf of the state, the 6 innovation
environments invest venture capital in
new innovative companies. The
contribution can either be in form of
loan or as a owner's share. To a
greater or lesser extend, all 6 units
has healthcare related companies in
their portfolio.
In 2011 the biotech and medico
companies attracted 355,2 million
DKK. This amounts to 39,6 % of the
overall capital for the innovation
environments.
The companies in the business
environments portfolio, attracts a high
amount of venture capital from private
investors. Though many of the companies
would never have seen the day of light,
had it not been because of the even
higher risk capital, provided by the
innovation environments.
Capital supply in companies where
Innovation environments have shares
within Biotech/medico. DKK in millions.
10,8
16 9,7
121
Danish venture
companies
Foreign venture capital
Business Angels
The 6 innovation environments:
• CAT Innovation A/S
• DTU Symbion Innovation A/S
• Innovation Midtvest A/S
• NOVI Innovation A/S
• Syddansk Teknologisk Innovation A/S
• Østjysk Innovation A/S
197,7
The innovation
environments
Other
223